Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Clinics in Perinatology|November 17, 2010
Antiretroviral pharmacology: special issues regarding pregnant women and neonatesMark Mirochnick, Brookie M Best, Diana F ClarkeThe Pediatric Infectious Disease Journal|October 18, 2016
Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected InfantsDiana F Clarke, Inci Yildirim, Ellen R CooperThe Pediatric Infectious Disease Journal|March 9, 2013
Raltegravir in vitro effect on bilirubin bindingDiana F Clarke, Ronald J Wong, Larissa Wenning, et al.Expert Review of Clinical Pharmacology|October 18, 2017
Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerationsDiana F Clarke, Martina Penazzato, Edmund Capparelli, et al.The Pediatric Infectious Disease Journal|March 22, 2018
In Vitro Study on the Effect of Maraviroc or Dolutegravir on Bilirubin to Albumin BindingCynthia N Schreiner, Charles E Ahlfors, Ronald J Wong, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110Diana F Clarke, Mark Mirochnick, Edward P Acosta, et al.Journal of the Pediatric Infectious Diseases Society|April 30, 2020
"Meds-in-Hand" Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure ProphylaxisRachel L Epstein, Nicole Penwill, Diana F Clarke, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2021
Optimizing Dolutegravir Initiation in Neonates Using Population Pharmacokinetic Modeling and SimulationJoseph Piscitelli, Mina Nikanjam, Brookie M Best, et al.CPT: Pharmacometrics & Systems Pharmacology|December 8, 2022
Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19Xiaomei I Liu, André Dallmann, Kristina Brooks, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2014
Raltegravir pharmacokinetics in neonates following maternal dosingDiana F Clarke, Edward P Acosta, Matthew L Rizk, et al.Pageof 2